Ligustrazine Phosphate Tablets

Ligustrazine phosphate has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation and promoting blood circulation and removing blood stasis. It also has the effect of disaggregating aggregated platelets.

The main ingredient of this product is ligustrazine phosphate, and its chemical name is: 2,3,5,6-tetramethylpyrazine phosphate.

This product is a sugar-coated tablet, which appears white or off-white after removing the sugar coating.

Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by insufficient blood supply to the brain, cerebral thrombosis, and cerebral embolism.

Oral administration: 50-100 mg at a time, 3 times a day, 1 month as a course of treatment, follow the doctor's advice.

Occasionally, stomach discomfort, dry mouth, and drowsiness may occur. Taking the medicine after meals can avoid or reduce side effects.

It is contraindicated in patients with cerebral hemorrhage or bleeding tendency.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: It is not clear. Precautions for the elderly: It is not clear.

This product is highly acidic and should not be used in combination with alkaline drugs.

Keep away from light and store in airtight container.

50mg

24 months

GuangDongBangMinPharmaceutical Co., Ltd.

• Founded in:

  2001-07-27

• Address:

  No. 33, Bangmin Road, High-tech Development Zone, Jianghai District, Jiangmen City

• Tax NO.:

  91440700730460367E

• Registered Funds:

  64.038 million yuan

• Website:

  Log in to view

• Email:

  Log in to view